Eloxx Pharmaceuticals, Inc. Proceeds from Notes Payable
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2017-05-22
- 2017-03-31: Proceeds from Notes Payable 9 month $800.00K.
- 2016-03-31: Proceeds from Notes Payable 9 month $0.00.
| Period end | Proceeds from Notes Payable 9 month |
|---|---|
| 2017-03-31 | $800.00K 10-Q · filed 2017-05-22 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-22 |